What Do I Do Now?: Assessment and Management of Neuropsychiatric Symptoms in Neurocognitive Disorders
Tuesday April 24, 2018 1:00 pm to 3:00 pm
Aging, Dementia, Cognitive, and Behavioral Neurology
Daniel Kaufer MD, FAAN
This course will outline practical, systematic approaches to assessing and managing neuropsychiatric symptoms in neurocognitive disorders. Neuropsychiatric symptoms reflect cerebral dysfunction across a wide range of cortical and subcortical networks. They represent core features of dementia with Lewy bodies and behavioral variant frontotemporal degeneration, and are often clinically significant co-morbidities in Alzheimer's disease and other neurocognitive disorders. This year's course will follow the "What Do I Do Now?" format, including cases that illustrate common management decision points and using ARS to facilitate audience participation. Audience members will be invited to submit challenging cases prior to the course. Faculty will review the spectrum of neuropsychiatric disturbances seen in neurocognitive disorders, discuss practical clinical assessment techniques based on informant report, and outline a systematic approach to management including pharmacological and non-pharmacological interventions.
Participants should be able to efficiently identify and assess common neuropsychiatric symptoms; develop a systematic approach to formulating a flexible, comprehensive treatment plan; select appropriate pharmacological therapies for specific target symptoms to ensure safety, improve quality of life, and minimize patient and caregiver distress; better understand possible iatrogenicity and minimize risks associated with polypharmacy; and become familiar with behavioral modification techniques and use community resources for caregiver education and support.
Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement, Professionalism, Systems-Based Practice
Program Speakers - Tentative
1:00 PM - 1:20 PM
Daniel Kaufer MD, FAAN
1:20 PM - 1:40 PM
Neuropsychiatric Symptom Management
Douglas W. Scharre MD
1:40 PM - 2:50 PM
Case Presentations with ARS
Daniel Kaufer MD, FAAN, Douglas W. Scharre MD
2:50 PM - 3:00 PM
Wrap-Up / Discussion
Daniel Kaufer, MD, FAAN
Dr. Kaufer has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Axovant, Takeda, Abbvie. Dr. Kaufer has received research support from Abbvie, Axovant Sciences, Navidea Biopharmaceuticals.
Douglas W. Scharre, MD
Dr. Scharre has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Eli Lilly and BrainTest. Dr. Scharre has received royalty, license fees, or contractual rights payments from BrainTest, Inc. for a licensed invention. Dr. Scharre has received research support from Biogen, Merck, Eli Lilly, BrainTest, AstraZeneca, Avanir, Roche, Axovnt and Neurim.
Ready to register for the 2018 AAN Annual Meeting?